Analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report issued on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
NASDAQ:CALA opened at $0.02 on Tuesday. The company has a fifty day moving average of $0.02 and a two-hundred day moving average of $0.03. Calithera Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.50.
About Calithera Biosciences
Recommended Stories
- Five stocks we like better than Calithera Biosciences
- 3 Grocery Stocks That Are Proving They Are Still Essential
- AMD is Down 35%. Now is the Time to Buy the Dip
- What Makes a Stock a Good Dividend Stock?
- Amazon Stands Tall: New Highs Are in Sight
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.